These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28601706)

  • 1. Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study.
    Boerman LM; Maass SWMC; van der Meer P; Gietema JA; Maduro JH; Hummel YM; Berger MY; de Bock GH; Berendsen AJ
    Eur J Cancer; 2017 Aug; 81():56-65. PubMed ID: 28601706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.
    Dong SJ; de las Fuentes L; Brown AL; Waggoner AD; Ewald GA; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Aug; 19(8):1017-25. PubMed ID: 16880097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.
    Jacobse JN; Steggink LC; Sonke GS; Schaapveld M; Hummel YM; Steenbruggen TG; Lefrandt JD; Nuver J; Crijns APG; Aleman BMP; van der Meer P; Gietema JA; van Leeuwen FE
    Eur J Heart Fail; 2020 Feb; 22(2):338-346. PubMed ID: 31696625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention.
    Siva Sankara C; Rajasekhar D; Vanajakshamma V; Praveen Kumar BS; Vamsidhar A
    Indian Heart J; 2015; 67(4):318-27. PubMed ID: 26304563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer.
    Brouwer CA; Postma A; Vonk JM; Zwart N; van den Berg MP; Bink-Boelkens MT; Dolsma WV; Smit AJ; de Vries EG; Tissing WJ; Gietema JA
    Eur J Cancer; 2011 Nov; 47(16):2453-62. PubMed ID: 21696947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up.
    Murtagh G; Lyons T; O'Connell E; Ballot J; Geraghty L; Fennelly D; Gullo G; Ledwidge M; Crown J; Gallagher J; Watson C; McDonald KM; Walshe JM
    Breast Cancer Res Treat; 2016 Apr; 156(3):501-506. PubMed ID: 27060913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular dysfunction in repaired tetralogy of Fallot: incidence and impact on atrial arrhythmias at long term-follow up.
    Ait Ali L; Trocchio G; Crepaz R; Stuefer J; Stagnaro N; Siciliano V; Molinaro S; Sicari R; Festa P
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1441-1449. PubMed ID: 27318953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].
    Swiatkiewicz I; Grubecki A; Koziński M; Fabiszak T; Białoszyński T; Sukiennik A; Kubica J
    Pol Merkur Lekarski; 2006 Mar; 20(117):289-92. PubMed ID: 16780257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening of asymptomatic left ventricular systolic dysfunction in a population sample at high cardiovascular risk in Lombardy (Italy): the DAVID-Berg study].
    Gavazzi A; De Maria R; Grosu A; Iacovoni A; Fontana A; Gori M; Ferrari P; Canova P; Calabrese A; Filippi A; Rutili MR; Donzelli L; Parolini M; Senni M
    G Ital Cardiol (Rome); 2014 May; 15(5):313-22. PubMed ID: 25002172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide.
    Abhayaratna WP; Marwick TH; Becker NG; Jeffery IM; McGill DA; Smith WT
    Am Heart J; 2006 Nov; 152(5):941-8. PubMed ID: 17070165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of preoperative N-terminal pro-brain natriuretic peptide in non-cardiac surgery of elderly patients with normal left ventricular systolic function.
    Kim IJ; Moon JY; Ko EJ; Lim YM; Kim SH; Yang WI; Sung JH; Lim SW; Cha DH
    Geriatr Gerontol Int; 2016 Oct; 16(10):1109-1116. PubMed ID: 26336935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy.
    Koelwyn GJ; Lewis NC; Ellard SL; Jones LW; Gelinas JC; Rolf JD; Melzer B; Thomas SM; Douglas PS; Khouri MG; Eves ND
    Oncologist; 2016 Feb; 21(2):141-9. PubMed ID: 26764251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP predicts impaired myocardial function in newly diagnosed hypertensive patients with preserved ejection fraction.
    Sahin DY; Gür M; Elbasan Z; Kırım S; Uçar H; Seker T; Kaypaklı O; Uysal OK; Kıvrak A; Koyunsever NY; Akıllı RE; Çaylı M
    Clin Exp Hypertens; 2014; 36(5):289-94. PubMed ID: 23865488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.
    Ledwidge M; Gallagher J; Conlon C; Tallon E; O'Connell E; Dawkins I; Watson C; O'Hanlon R; Bermingham M; Patle A; Badabhagni MR; Murtagh G; Voon V; Tilson L; Barry M; McDonald L; Maurer B; McDonald K
    JAMA; 2013 Jul; 310(1):66-74. PubMed ID: 23821090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus.
    Salem M; El Behery S; Adly A; Khalil D; El Hadidi E
    Pediatr Diabetes; 2009 Dec; 10(8):513-21. PubMed ID: 19708908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.